CollPlant Biotechnologies annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Revenue Growth & History (CLGN)
CollPlant Biotechnologies reported $2.4M in revenue for fiscal 2025, an increase of 360.39% from the previous fiscal year.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.4M | $1.9M | +360.39% |
| 2024 | 2024-12-31 | $515,000 | −$10.4M | −95.30% |
| 2023 | 2023-12-31 | $11.0M | $10.7M | +3565.22% |
| 2022 | 2022-12-31 | $299,000 | −$15.3M | −98.09% |
| 2021 | 2021-12-31 | $15.6M | $9.5M | +154.86% |
| 2020 | 2020-12-31 | $6.1M | $3.8M | +164.75% |
| 2019 | 2019-12-31 | $2.3M | −$2.7M | −53.77% |
| 2018 | 2018-12-31 | $5.0M | $4.6M | +982.94% |
| 2017 | 2017-12-31 | $463,000 | — | — |
CollPlant Biotechnologies quarterly revenue
Q2.18
Q2.19
Q2.20
Q2.21
Q2.22
Q2.23
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $73,000 | −$2.0M | −96.45% |
| Q4 2025 | 2025-12-31 | $60,000 | — | — |
| Q3 2025 | 2025-09-30 | $77,000 | — | — |
| Q2 2025 | 2025-06-30 | $179,000 | −$70,000 | −28.11% |
| Q1 2025 | 2025-03-31 | $2.1M | — | — |
| Q2 2024 | 2024-06-30 | $249,000 | −$9.9M | −97.55% |
| Q2 2023 | 2023-06-30 | $10.2M | $10.1M | +15330.30% |
| Q2 2022 | 2022-06-30 | $66,000 | −$625,000 | −90.45% |
| Q2 2021 | 2021-06-30 | $691,000 | −$132,000 | −16.04% |
| Q2 2020 | 2020-06-30 | $823,000 | $217,000 | +35.81% |
| Q2 2019 | 2019-06-30 | $606,000 | $424,000 | +232.97% |
| Q2 2018 | 2018-06-30 | $182,000 | — | — |
CollPlant Biotechnologies revenue growth trends
Over the last five reported fiscal years, revenue declined from $6.1M to $2.4M, a compound annual decline of 17.32%. CollPlant Biotechnologies's latest reported quarter, Q1 2026, generated $73,000 in revenue, a decrease of 96.45% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review CollPlant Biotechnologies source filings ↗